Core B: Human Tissue and Genomics Core

$249,634P01FY2022DKNIH

Univ Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Paper 39677473 Paper 39464142 Paper 39286616 Paper 39215865 Paper 39146793 Paper 39113097 Paper 38630807 Paper 38385744 Paper 38370739 Paper 38328082 Paper 38302662 Paper 38019944 Paper 37236155 Paper 36712050 Paper 36384110 Paper 36336910 Paper 36218393 Paper 35935217 Paper 35765004 Paper 35705368 Paper 35533983 Paper 35482409 Paper 35413017 Paper 35401533 Paper 35317738 Paper 35158099 Paper 34758081 Paper 34697412 Paper 34684567 Paper 34389789 Paper 34188154 Paper 34050144 Paper 33767427 Paper 33692569 Paper 33505023 Paper 33479908 Paper 33406262 Paper 33269348 Paper 33122357 Paper 33064972 Paper 33024279 Paper 33017103 Paper 32961355 Paper 32941596 Paper 32764096 Paper 32561494 Paper 32469069 Paper 32170007 Paper 32153125 Paper 32133003 Paper 32006212 Paper 31959971 Paper 31756561 Paper 31558613 Paper 31546615 Paper 31482438 Paper 31391308 Paper 31220352 Paper 31211700 Paper 31179826 Paper 30902577 Paper 30566882 Paper 30559741 Paper 30504889 Paper 30393787 Paper 30312415 Paper 30282822 Paper 30243353 Paper 30212649 Paper 29982468 Paper 29055911 Paper 28850571 Paper 28401939 Paper 28385711 Paper 28288099 Paper 28273475 Paper 27769810 Paper 27742763 Paper 27159132 Paper 27147411 Paper 27030950 Paper 26982365 Paper 26971998 Paper 26849721 Paper 26378020 Paper 26374098 Paper 26240332 Paper 26164662 Paper 26107252 Paper 26034781 Paper 25750733 Paper 25730872 Paper 25595930 Paper 24963153 Paper 24766894 Paper 24634494 Paper 24560620 Paper 24373309 Paper 21679711

Abstract

Human Tissue and Genomics Core Summary The overall objective of the Core is to provide resources and expertise to perform and analyze data from gene expression, miRNA expression, ChIP-seq, and microbiota profiling assays that identify disease-specific transcriptional patterns and shifts in microbiota abundance in tissue of patients with IBD. Additionally, the Core will enable project investigators to perform functional validation in patient- derived organoid experimental systems to substantiate and guide their hypotheses obtained in patient samples and animal models. This will be facilitated through access to human samples from well- characterized adult and pediatric IBD patients and controls.

View original record on NIH RePORTER →